Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Immunotherapeutic Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Immunotherapeutic Drugsmarket, defines the market attractiveness level of Immunotherapeutic Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Immunotherapeutic Drugs industry, describes the types of Immunotherapeutic Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Immunotherapeutic Drugs market and the development prospects and opportunities of Immunotherapeutic Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Immunotherapeutic Drugs market in Chapter 13.
By Player:
Amgen
Merck
ELI Lilly
Bristol-Mysers Squibb
GlaxoSmithKline
Novartis
AstraZeneca
Roche
Johnson and Johnson
AbbVie
By Type:
Monoclonal Antibody
Vaccines
Checkpoint Inhibitor
Interferon
By End-User:
Hospitals
Clinics
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Immunotherapeutic Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Immunotherapeutic Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Immunotherapeutic Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Immunotherapeutic Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Immunotherapeutic Drugs Market Analysis and Outlook to 2022
-
7.1 Global Immunotherapeutic Drugs Consumption (2017-2022)
-
7.2 United States Immunotherapeutic Drugs Consumption (2017-2022)
-
7.3 Europe Immunotherapeutic Drugs Consumption (2017-2022)
-
7.4 China Immunotherapeutic Drugs Consumption (2017-2022)
-
7.5 Japan Immunotherapeutic Drugs Consumption (2017-2022)
-
7.6 India Immunotherapeutic Drugs Consumption (2017-2022)
-
7.7 South Korea Immunotherapeutic Drugs Consumption (2017-2022)
8 Region and Country-wise Immunotherapeutic Drugs Market Analysis and Outlook to 2028
-
8.1 Global Immunotherapeutic Drugs Consumption Forecast (2022-2028)
-
8.2 United States Immunotherapeutic Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Immunotherapeutic Drugs Consumption Forecast (2022-2028)
-
8.4 China Immunotherapeutic Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Immunotherapeutic Drugs Consumption Forecast (2022-2028)
-
8.6 India Immunotherapeutic Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Immunotherapeutic Drugs Consumption Forecast (2022-2028)
9 Global Immunotherapeutic Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Immunotherapeutic Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Monoclonal Antibody Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Vaccines Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Checkpoint Inhibitor Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Interferon Consumption and Growth Rate (2017-2022)
-
9.2 Global Immunotherapeutic Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Global Immunotherapeutic Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Immunotherapeutic Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Monoclonal Antibody Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Checkpoint Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Interferon Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Immunotherapeutic Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Immunotherapeutic Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Immunotherapeutic Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Immunotherapeutic Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Immunotherapeutic Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Immunotherapeutic Drugs Market Competitive Analysis
-
14.1 Amgen
-
14.1.1 Amgen Company Details
-
14.1.2 Amgen Immunotherapeutic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Amgen Immunotherapeutic Drugs Product and Service
-
14.2 Merck
-
14.2.1 Merck Company Details
-
14.2.2 Merck Immunotherapeutic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Merck Immunotherapeutic Drugs Product and Service
-
14.3 ELI Lilly
-
14.3.1 ELI Lilly Company Details
-
14.3.2 ELI Lilly Immunotherapeutic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 ELI Lilly Immunotherapeutic Drugs Product and Service
-
14.4 Bristol-Mysers Squibb
-
14.4.1 Bristol-Mysers Squibb Company Details
-
14.4.2 Bristol-Mysers Squibb Immunotherapeutic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Bristol-Mysers Squibb Immunotherapeutic Drugs Product and Service
-
14.5 GlaxoSmithKline
-
14.5.1 GlaxoSmithKline Company Details
-
14.5.2 GlaxoSmithKline Immunotherapeutic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 GlaxoSmithKline Immunotherapeutic Drugs Product and Service
-
14.6 Novartis
-
14.6.1 Novartis Company Details
-
14.6.2 Novartis Immunotherapeutic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Novartis Immunotherapeutic Drugs Product and Service
-
14.7 AstraZeneca
-
14.7.1 AstraZeneca Company Details
-
14.7.2 AstraZeneca Immunotherapeutic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 AstraZeneca Immunotherapeutic Drugs Product and Service
-
14.8 Roche
-
14.8.1 Roche Company Details
-
14.8.2 Roche Immunotherapeutic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Roche Immunotherapeutic Drugs Product and Service
-
14.9 Johnson and Johnson
-
14.9.1 Johnson and Johnson Company Details
-
14.9.2 Johnson and Johnson Immunotherapeutic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Johnson and Johnson Immunotherapeutic Drugs Product and Service
-
14.10 AbbVie
-
14.10.1 AbbVie Company Details
-
14.10.2 AbbVie Immunotherapeutic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 AbbVie Immunotherapeutic Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Immunotherapeutic Drugs
-
Figure Immunotherapeutic Drugs Picture
-
Table Global Immunotherapeutic Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Immunotherapeutic Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Immunotherapeutic Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Immunotherapeutic Drugs Consumption by Country (2017-2022)
-
Figure United States Immunotherapeutic Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Immunotherapeutic Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Immunotherapeutic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Immunotherapeutic Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Immunotherapeutic Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Immunotherapeutic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Immunotherapeutic Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Immunotherapeutic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Immunotherapeutic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Immunotherapeutic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Immunotherapeutic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Immunotherapeutic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Immunotherapeutic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Monoclonal Antibody Consumption and Growth Rate (2017-2022)
-
Figure Global Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Global Checkpoint Inhibitor Consumption and Growth Rate (2017-2022)
-
Figure Global Interferon Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Monoclonal Antibody Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Checkpoint Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Interferon Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Immunotherapeutic Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Immunotherapeutic Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Immunotherapeutic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Immunotherapeutic Drugs Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Immunotherapeutic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Immunotherapeutic Drugs Product and Service
-
Table ELI Lilly (Foundation Year, Company Profile and etc.)
-
Table ELI Lilly Immunotherapeutic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table ELI Lilly Immunotherapeutic Drugs Product and Service
-
Table Bristol-Mysers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Mysers Squibb Immunotherapeutic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Mysers Squibb Immunotherapeutic Drugs Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Immunotherapeutic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Immunotherapeutic Drugs Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Immunotherapeutic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Immunotherapeutic Drugs Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Immunotherapeutic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Immunotherapeutic Drugs Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Immunotherapeutic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Immunotherapeutic Drugs Product and Service
-
Table Johnson and Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson and Johnson Immunotherapeutic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson and Johnson Immunotherapeutic Drugs Product and Service
-
Table AbbVie (Foundation Year, Company Profile and etc.)
-
Table AbbVie Immunotherapeutic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Immunotherapeutic Drugs Product and Service
-
